Cure TV

An advocate discusses vital patient-provider conversations to promote the best care for individuals with chronic myeloid leukemia.

Having social media platforms to share breast cancer experiences changes the narrative for others who may empathize, a survivor and advocate said.

For patients with non-small lung cancer and brain metastases, it’s important to consent to shaving the scalp before tumor-treating fields therapy.

Patients with resectable stage 3 melanoma should talk about pretreatment therapy with their cancer care teams, an expert said.

Trodelvy led to better disease control and improved quality of life compared to chemotherapy in patients with triple-negative breast cancer.

Rybrevant plus Leclaza had promising response and progression-free survival rates in patients with EGFR-mutant non-small cell lung cancer.

Jessica McDade, B.S.N., RN, OCN, explains how she helps make her patients’ experience “a little less daunting” during their hospital stay.

For patients with blood cancers, CAR-T cell therapy has been a “mind-blowing” advancement for treatment in the cancer space.

During chemo shortages, nurses have helped many patients receive enough treatment, measuring them down to the “minutiae of the milligrams.”

While posttransplant Xospata did not worsen quality of life in patients with acute myeloid leukemia, it is essential that patients tell their providers about any side effects that they experience, an expert said.

Slower infusion rates of antiemetic drugs may help manage nausea and vomiting in patients with gastric or gastroesophageal junction cancers.

Patients with bladder cancer being treated with the immunotherapy agent, Keytruda, should not hesitate to call their oncology team if something does not feel right, an expert said.

Circulating tumor DNA can be a valuable tool in gastric cancer, but unanswered questions remain, an expert said.

“In my career of almost 30 years, I've never seen a liver cancer patient that did not have a chronic underlying liver disease,” Dr. Mindie H. Nguyen told CURE®.

Older adults with gastric cancer tended to have better outcomes when they walked 2,500 steps per day or more.

The use of FOLFOXIRI for metastatic colorectal cancer was lower than one what expert was expecting.

More facilitation is needed to ensure that clinicians can connect patients with breast cancer to clinical trials they may be eligible for.

An expert stressed the importance of finding a patient support group and asking questions after being diagnosed with kidney — or any other form — of cancer.

An expert discusses three crucial conversations about cancer care that patients should have with their health care providers.

A doctor reflected on what it was like treating patients with myeloproliferative neoplasms years ago and how much treatments have improved.

After being diagnosed with essential thrombocythemia, Marilyn Kay Edwards was not told much about her disease.

An expert spoke with CURE® about telehealth when it comes to ostomies within patients with bladder cancer, and overall within patients and survivors.

An artificial intelligence platform was able to tell the difference between patients with prefibrotic primary myelofibrosis and essential thrombocythemia. However, an expert says that there are considerations that patients must remember when it comes to the use of such programs.

Cervical cancer survival and Cervivor ambassador Kate Weissman provides advice on conversations patients with cervical cancer should be having with their care teams.

Valerie Frank and Sara M. Tolaney, MD, MPH, share advice for patients on managing treatment with antibody-drug conjugates and the importance of participating in clinical trials for HR+/HER2- metastatic breast cancer.

Valerie Frank and Sara M. Tolaney, MD, MPH, share advice for patients on managing treatment with antibody-drug conjugates and the importance of participating in clinical trials for HR+/HER2- metastatic breast cancer.

Valerie Frank and Sara M. Tolaney, MD, MPH, share advice for patients on managing treatment with antibody-drug conjugates and the importance of participating in clinical trials for HR+/HER2- metastatic breast cancer.

A childhood cancer specialist discusses how oncology drug shortages may affect the treatment of children with cancer.